This webinar reviews the evidence and discusses practical treatment strategies that clinicians can take in managing opioid agonist pharmacotherapies for opioid-use disorder in patients using prescribed or illicit benzodiazepines or other CNS depressants.
The session features Dr. Brian Hurley, MBA, DFASAM, an addiction psychiatrist who is the Medical Director of Co-Occurring Disorder Services at the Los Angeles County Department of Mental Health and Assistant Professor of Addiction Medicine at UCLA.
Who should watch this webinar?
Clinicians prescribing buprenorphine and Medication Assisted Treatment team members
Our big takeaways:
- Dr. Hurley identifies the risks associated with concurrent use of benzodiazepines and opioid agonist pharmacotherapies for opioid-use disorder.
- He covers the core treatment principles for opioid agonist medication management in patients with opioid-use disorder using benzodiazepines.
- And he offers a treatment strategy for patients with opioid-use disorder that use benzodiazepines.
Find this useful or interesting? We’re constantly sharing stuff like this. Sign up to receive our newsletter to stay in the loop.
